SavedAdd your journal

Journals / Haydarpaşa Numune Medical Journal / 2020 / Cilt: 60 - Sayı: 2

Percutaneous Transluminal Angioplasty of Infrapopliteal Arteries in Patients with Intermittent Claudication:Acute and Six-Month-Results

Cesur SAMANCI
Yılmaz ÖNAL
Pages
107–112
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Large-scale, multicenter, prospective studies that systematically evaluate existing infrapopliteal treatment methods are needed to develop contemporary, proven treatment standards.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Introduction: Critical leg ischemia represents the final stage of atherosclerotic peripheral arterial disease (PAD).
📊
Key Findings & Data:None of the patients received infrapopliteal stents, and only balloon angioplasty was performed.Results: In our study, 41 vessels with a total of 48 lesions in 31 patients were treated.
💡
Conclusion & Impact:Large-scale, multicenter, prospective studies that systematically evaluate existing infrapopliteal treatment methods are needed to develop contemporary, proven treatment standards.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

Introduction: Critical leg ischemia represents the final stage of atherosclerotic peripheral arterial disease (PAD). Patients affected by critical leg ischemia are the most complex subset of PAD and typically have chronic pathological consequences of hypertension, hyperlipidemia, diabetes and renal failure.Methods: In this study, we evaluated the early and sixth-month outcomes of percutaneous transluminal angioplasty (PTA) in patients with stenosis or occlusion at the infrapopliteal level. Only one leg was treated in one session. None of the patients received infrapopliteal stents, and only balloon angioplasty was performed.Results: In our study, 41 vessels with a total of 48 lesions in 31 patients were treated. The primary patency rate of the vascular segments treated at follow-up was 72.9%.Discussion and Conclusion: In PTA, failure in the procedure and loss of patency are the main therapeutic challenges to be solved. Large-scale, multicenter, prospective studies that systematically evaluate existing infrapopliteal treatment methods are needed to develop contemporary, proven treatment standards.

🔖

Cite This Article

SAMANCI, C., ÖNAL, Y. (2020). Percutaneous Transluminal Angioplasty of Infrapopliteal Arteries in Patients with Intermittent Claudication:Acute and Six-Month-Results. Haydarpaşa Numune Medical Journal, Cilt: 60 - Sayı: 2, 107–112. https://ajindex.com/articles/160532

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Balkanay OO, Ömeroğlu SN. Yaşlılarda periferik arter hastalığı-na yaklaşım. Turk Kardiyol Dern Ars 2017;45:96–101
  2. Hunt BD, Popplewell MA, Davies H, Meecham L, Jarrett H, Bate G, et al; BASIL-3 Collaborative Group. BAlloon versus Stenting in severe Ischaemia of the Leg-3 (BASIL-3): study protocol for a randomised controlled trial. Trials 2017;18:224
  3. Dotter CT, Judkıns MP. Translumınal Treatment of Arterıo-sclerotıc Obstructıon. Descrıptıon of a New Technıc and a Prelımınary Report of its Applıcatıon. Circulation 1964;30:654–70
  4. Grüntzig A, Hopff H. [Percutaneous recanalization after chron-ic arterial occlusion with a new dilator-catheter (modification of the Dotter technique) (author's transl)]. [Article in German]. Dtsch Med Wochenschr 1974;99:2502–10, 2511
  5. Abu Dabrh AM, Steffen MW, Undavalli C, Asi N, Wang Z, Elamin MB, et al. The natural history of untreated severe or critical limb ischemia. J Vasc Surg 2015;62:1642–51.e3
  6. National Institute for Health and Clinical Excellence. Lower limb peripheral arterial disease. Diagnosis and management. NICE clinical guideline 147. National Clinical Guideline Centre; 2012
  7. Swaminathan A, Vemulapalli S, Patel MR, Jones WS. Lower ex-tremity amputation in peripheral artery disease: improving patient outcomes. Vasc Health Risk Manag 2014;10:417–24
  8. Diamantopoulos A, Katsanos K. Treating femoropopliteal dis-ease: established and emerging technologies. Semin Inter-vent Radiol 2014;31:345–352
  9. Pastromas G, Katsanos K, Krokidis M, Karnabatidis D, Spiliopou-los S. Emerging stent and balloon technologies in the femoro-popliteal arteries. ScientificWorldJournal 2014;2014:695402
  10. Mustapha JA, Finton SM, Diaz-Sandoval LJ, Saab FA, Miller LE. Percutaneous Transluminal Angioplasty in Patients With Infrapopliteal Arterial Disease: Systematic Review and Me-ta-Analysis. Circ Cardiovasc Interv 2016;9:e003468
  11. Kudo T, Chandra FA, Ahn SS. The effectiveness of percutane-ous transluminal angioplasty for the treatment of critical limb ischemia: a 10-year experience. J Vasc Surg 2005;41:423–35
  12. Karnabatidis D, Spiliopoulos S, Diamantopoulos A, Katsanos K, Kagadis GC, Kakkos S, et al. Primary everolimus-eluting stenting versus balloon angioplasty with bailout bare metal stenting of long infrapopliteal lesions for treatment of critical limb ischemia. J Endovasc Ther 2011;18:1–12
  13. Davies MG, El-Sayed HF. Outcomes of Isolated Tibial Endovas-cular Interventions for Tissue Loss in CLI Patients on Hemo